Work

Remission instead of eradication? MEK inhibition in primary refractory childhood LCH

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-7281

Authors: Alexander Desuki, Claudia Paret, Ina Oehme, Heike Peterziel, Olaf Witt, Francesca Alt, Olaf Beck, Khalifa ElMalki, Arthur Wingerter, Julia Heider, Achim Reckmann, Gundula Staatz, Thomas Lehrnbecher, Joerg Faber, Milen Minkov, Alexandra Russo

Institutions: Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, German Cancer Research Center, University Hospital Heidelberg, National Center for Tumor Diseases, Hopp Children's Cancer Center Heidelberg, Deutsches Konsortium für Translationale Krebsforschung, Goethe University Frankfurt, University Hospital Frankfurt, St Anna Children's Hospital, St. Anna Children's Cancer Research Institute

Language: English

Topic: Histiocytic Disorders and Treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417069299

Cites:

Cited by:

Related to: